https://orcid.org/0000-0002-8539-4891
Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Manoj Kumar Sarangi, Sasmita Padhi, Gautam Rath, Sitansu Sekhar Nanda & Dong Kee Yi. (2022) Success of nano-vaccines against COVID-19: a transformation in nanomedicine. Expert Review of Vaccines 21:12, pages 1739-1761.
Read now
Read now
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth & Waleed M Hussein. (2022) Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. International Journal of Nanomedicine 17, pages 869-900.
Read now
Read now
Christopher P. Karch & Gary R. Matyas. (2021) The current and future role of nanovaccines in HIV-1 vaccine development. Expert Review of Vaccines 20:8, pages 935-944.
Read now
Read now
Xinyuan Zhang, Zhigang Zhang, Ningshao Xia & Qinjian Zhao. (2021) Carbohydrate-containing nanoparticles as vaccine adjuvants. Expert Review of Vaccines 20:7, pages 797-810.
Read now
Read now
Rosana Simón-Vázquez, Mercedes Peleteiro & África González-Fernández. (2020) Polymeric nanostructure vaccines: applications and challenges. Expert Opinion on Drug Delivery 17:7, pages 1007-1023.
Read now
Read now
Mario Di Gioacchino, Claudia Petrarca, Alessia Gatta, Gilda Scarano, Anila Farinelli, Loredana Della Valle, Arianna Lumaca, Pietro Del Biondo, Roberto Paganelli & Luca Di Giampaolo. (2020) Nanoparticle-based immunotherapy: state of the art and future perspectives. Expert Review of Clinical Immunology 16:5, pages 513-525.
Read now
Read now
Lev A. Dykman. (2020) Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases. Expert Review of Vaccines 19:5, pages 465-477.
Read now
Read now
Iván del Moral-Sánchez & Kwinten Sliepen. (2019) Strategies for inducing effective neutralizing antibody responses against HIV-1. Expert Review of Vaccines 18:11, pages 1127-1143.
Read now
Read now
Articles from other publishers (76)
Natália Cristina Dalibera, Monica Josiane Rodrigues-Jesus, Robert Andreata-Santos, Luiz Mário Ramos Janini, Aline Furtado Oliveira, Adriano Rodrigues Azzoni, Luís Carlos de Souza Ferreira & Marianna T. P. Favaro. (2023) SARS-CoV-2 Nanovaccine Composed of Microfluidic-Produced Gold Nanoparticles Induces Neutralizing Immune Responses. ACS Applied Nano Materials.
Crossref
Crossref
Rahul Tiwari, Rohit P. Gupta, Vishal K. Singh, Awnish Kumar, Rajneesh, Prasoon Madhukar, Shyam Sundar, Vibhav Gautam & Rajiv Kumar. (2023) Nanotechnology-Based Strategies in Parasitic Disease Management: From Prevention to Diagnosis and Treatment. ACS Omega 8:45, pages 42014-42027.
Crossref
Crossref
Sebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira, Marcos C. Miranda, Natalie Brunette, Jana Kochmann, Martin Corcoran, Rebecca Skotheim, Annika Philomin, Alberto Cagigi, Brooke Fiala, Samuel Wrenn, Jessica Marcandalli, Fredrika Hellgren, Elizabeth A. Thompson, Ang Lin, Florian Gegenfurtner, Azad Kumar, Man Chen, Ganesh E. Phad, Barney S. Graham, Laurent Perez, Andrew J. Borst, Gunilla B. Karlsson Hedestam, Tracy J. Ruckwardt, Neil P. King & Karin Loré. (2023) Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses. Immunity 56:10, pages 2425-2441.e14.
Crossref
Crossref
Chittaranjan Baruah, Pankaj Das, Papari Devi, Palash Moni Saikia & Bhabesh Deka. (2023) The emergence of nanovaccines as a new paradigm in virological vaccinology: a review. Exploration of Immunology, pages 361-383.
Crossref
Crossref
Neval SEVINÇ OZDEMIRDmitry BelyaevManuel Nieto CastroSascha BalakinJoerg OpitzHevi WihadmadyatamiRahmi AnggraeniDeniz YücelHalime KenarNatalia BeshchasnaIka Dewi AnaVasif N Hasirci. (2023) Advances in <i>in vitro</i> blood-air barrier models and the use of nanoparticles in COVID-19 research. Tissue Engineering Part B: Reviews.
Crossref
Crossref
K. Manju, S. Niranjan Raj, H. K. Ranjini, S. Chandra Nayaka, P. Ashwini, S. Satish, M. N. Nagendra Prasad, Raghuraj Singh Chouhan & Syed Baker. (2023) Nanovaccines to combat drug resistance: the next-generation immunisation. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Crossref
Nicholas J. Tursi, Ziyang Xu, Daniel W. Kulp & David B. Weiner. (2023) Gene‐encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Crossref
Payton A.-B. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S. Arunachalam, Mengyun Hu, Ozan S. Kumru, Mary Kate Morris, Jane Fontenot, Lisa Shirreff, Jonathan Do, Ya-Chen Cheng, Gayathri Vasudevan, Mark B. Feinberg, Francois J. Villinger, Carl Hanson, Sangeeta B. Joshi, David B. Volkin, Bali Pulendran & Peter S. Kim. (2023) A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. Nature Communications 14:1.
Crossref
Crossref
Aryamav Pattnaik, Bikash R. Sahoo, Lucas R. Struble, Gloria E. O. Borgstahl, You Zhou, Rodrigo Franco, Raul G. Barletta, Fernando A. Osorio, Thomas M. Petro & Asit K. Pattnaik. (2023) A Ferritin Nanoparticle-Based Zika Virus Vaccine Candidate Induces Robust Humoral and Cellular Immune Responses and Protects Mice from Lethal Virus Challenge. Vaccines 11:4, pages 821.
Crossref
Crossref
Prashamsa Koirala, Sung‐Po R. Chen, Jennifer C. Boer, Zeinab G. Khalil, Cyril Deceneux, Georgia Goodchild, Lantian Lu, Mohammad Omer Faruck, Ahmed O. Shalash, Sahra Bashiri, Robert J. Capon, Waleed M. Hussein, Michael J. Monteiro, Magdalena Plebanski, Istvan Toth & Mariusz Skwarczynski. (2023) Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape. Advanced Functional Materials 33:12.
Crossref
Crossref
Seong A. Kim, Yeram Lee, Yeju Ko, Seohyun Kim, Gi Beom Kim, Na Kyeong Lee, Wonkyung Ahn, Nayeon Kim, Gi-Hoon Nam, Eun Jung Lee & In-San Kim. (2023) Protein-based nanocages for vaccine development. Journal of Controlled Release 353, pages 767-791.
Crossref
Crossref
Myriam Lamrayah, Fanny Charriaud, Manon Desmares, Céline Coiffier, Simon Megy, Evelyne Colomb, Raphaël Terreux, Julie Lucifora, David Durantel & Bernard Verrier. (2023) Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus. Antiviral Research 209, pages 105483.
Crossref
Crossref
Ivan Aranha. 2023. Nanotechnology and Human Health. Nanotechnology and Human Health
363
380
.
Ángel de Jesús Jiménez-Chávez & Leticia Moreno-Fierros. (2022) Nonenveloped Virus-Like Particles: A Promising Antigen-Delivery Strategy for the Induction of Antitumor Immune Responses. Nano LIFE 12:04.
Crossref
Crossref
Mitch Brinkkemper, Tim S. Veth, Philip J.M. Brouwer, Hannah Turner, Meliawati Poniman, Judith A. Burger, Joey H. Bouhuijs, Wouter Olijhoek, Ilja Bontjer, Jonne L. Snitselaar, Tom G. Caniels, Cynthia A. van der Linden, Rashmi Ravichandran, Julien Villaudy, Yme U. van der Velden, Kwinten Sliepen, Marit J. van Gils, Andrew B. Ward, Neil P. King, Albert J.R. Heck & Rogier W. Sanders. (2022) Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses. iScience 25:12, pages 105649.
Crossref
Crossref
Zih-Yao Lin, Yu-Hung Chen, Yan-Wei Wu & Mei-Chin Chen. (2022) Highly Stable Gold Nanoparticle-Antigen Conjugates with Self-Adjuvanting Property for Induction of Robust Antigen-Specific Immune Responses. Colloids and Surfaces B: Biointerfaces, pages 112897.
Crossref
Crossref
Veerupaxagouda Patil, Juan F. Hernandez-Franco, Harm HogenEsch & Gourapura J. Renukaradhya. (2022) Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives. Frontiers in Immunology 13.
Crossref
Crossref
Min He, Wenxiang Zhang, Zheyi Liu, Lingqiang Zhou, Xiaoming Cai, Ruibin Li, Yuanjiang Pan & Fangjun Wang. (2022) The interfacial interactions of nanomaterials with human serum albumin. Analytical and Bioanalytical Chemistry 414:16, pages 4677-4684.
Crossref
Crossref
Kara-Lee Aves, Christoph M. Janitzek, Cyrielle E. Fougeroux, Thor G. Theander & Adam F. Sander. (2022) Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature. Pharmaceutics 14:6, pages 1301.
Crossref
Crossref
Jesús Antonio López‐Carvallo, José Manuel Mazón‐Suástegui, Guadalupe Fabiola Arcos‐Ortega, Miguel Ángel Hernández‐Oñate, Dariel Tovar‐Ramírez, Fernando Abasolo‐Pacheco & Milagro García‐Bernal. (2021) Highly diluted bioactive compounds in marine aquaculture: A potential alternative for sustainable production. Reviews in Aquaculture 14:3, pages 1170-1193.
Crossref
Crossref
Seong A. Kim, Seohyun Kim, Gi Beom Kim, Jiyoung Goo, Nayeon Kim, Yeram Lee, Gi-Hoon Nam, Seungho Lim, Taeerk Kim, Ki Hwan Chang, Tae Gyu Lee, In-San Kim & Eun Jung Lee. (2022) A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations. International Journal of Molecular Sciences 23:11, pages 6123.
Crossref
Crossref
Egest J. Pone, Jenny E. Hernandez-Davies, Sharon Jan, Emily Silzel, Philip L. Felgner & D. Huw Davies. (2022) Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class Switching. Frontiers in Immunology 13.
Crossref
Crossref
Xiaoyi Jiang, Jian Wang, Xichen Zheng, Zhida Liu, Xinyu Zhang, Yuwei Li, Jonathan Wilhelm, Jun Cao, Gang Huang, Jinlan Zhang, Baran Sumer, Jayanthi Lea, Zhigang Lu, Jinming Gao & Min Luo. (2022) Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy. Journal for ImmunoTherapy of Cancer 10:5, pages e003960.
Crossref
Crossref
Anirban Sengupta, Mohammad Azharuddin, Noha Al-Otaibi & Jorma Hinkula. (2022) Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases. Vaccines 10:4, pages 505.
Crossref
Crossref
Chulwoo Kim, Jae-Deog Kim & Sang-Uk Seo. (2022) Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2. Journal of Microbiology 60:3, pages 335-346.
Crossref
Crossref
Moustafa T. Mabrouk, Wei‐Chiao Huang, Luis Martinez‐Sobrido & Jonathan F. Lovell. (2022) Advanced Materials for SARS‐CoV‐2 Vaccines. Advanced Materials 34:12.
Crossref
Crossref
Kylie M. Konrath, Kevin Liaw, Yuanhan Wu, Xizhou Zhu, Susanne N. Walker, Ziyang Xu, Katherine Schultheis, Neethu Chokkalingam, Himanshi Chawla, Jianqiu Du, Nicholas J. Tursi, Alan Moore, Jared Adolf-Bryfogle, Mansi Purwar, Emma L. Reuschel, Drew Frase, Matthew Sullivan, Benjamin Fry, Igor Maricic, Viviane M. Andrade, Christel Iffland, Max Crispin, Kate E. Broderick, Laurent M.P.F. Humeau, Ami Patel, Trevor R.F. Smith, Jesper Pallesen, David B. Weiner & Daniel W. Kulp. (2022) Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection. Cell Reports 38:5, pages 110318.
Crossref
Crossref
Iram Saba, Kaiser Wani, Suriya Rehman & Vipin Singh. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
541
553
.
Patrick D. Halley, Christopher R. Lucas, Nikša Roki, Nicholas J. Vantangoli, Kurtis P. Chenoweth & Carlos E. Castro. 2022. Biotechnologies for Gene Therapy. Biotechnologies for Gene Therapy
161
194
.
Evrim DÖNMEZ, Hafize Tuğba YÜKSEL DOLGUN & Şükrü KIRKAN. (2021) Nanopartiküler AşılarNanoparticular Vaccines. Journal of Anatolian Environmental and Animal Sciences 6:4, pages 578-584.
Crossref
Crossref
Hyo-Dong Sung, Nayeon Kim, Yeram Lee & Eun Jung Lee. (2021) Protein-Based Nanoparticle Vaccines for SARS-CoV-2. International Journal of Molecular Sciences 22:24, pages 13445.
Crossref
Crossref
Alina Popa & Sebastian Springer. (2021) Tailored Nanoparticles as Vaccine Components. Applied Sciences 11:24, pages 11898.
Crossref
Crossref
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent & Adam K. Wheatley. (2021) Current and future nanoparticle vaccines for COVID-19. eBioMedicine 74, pages 103699.
Crossref
Crossref
Cinja Kappel, Christine Seidl, Carolina Medina-Montano, Meike Schinnerer, Irina Alberg, Christian Leps, Julian Sohl, Ann-Kathrin Hartmann, Michael Fichter, Michael Kuske, Jenny Schunke, Gabor Kuhn, Ingrid Tubbe, David Paßlick, Dominika Hobernik, Rebekka Bent, Katharina Haas, Evelyn Montermann, Kerstin Walzer, Mustafa Diken, Manfred Schmidt, Rudolf Zentel, Lutz Nuhn, Hansjörg Schild, Stefan Tenzer, Volker Mailänder, Matthias Barz, Matthias Bros & Stephan Grabbe. (2021) Density of Conjugated Antibody Determines the Extent of Fc Receptor Dependent Capture of Nanoparticles by Liver Sinusoidal Endothelial Cells. ACS Nano 15:9, pages 15191-15209.
Crossref
Crossref
Sophia M. Reeder, Mamadou A. Bah, Nicholas J. Tursi, Rebekah C. Brooks, Ami Patel, Rianne Esquivel, Alison Eaton, Hugo Jhun, Jacqueline Chu, Kevin Kim, Ziyang Xu, Fidel Zavala & David B. Weiner. (2021)
Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from
Plasmodium
Infection in a Murine Model
. Infection and Immunity 89:10.
Crossref
Crossref
Thibault Colombani, Loek J. Eggermont, Zachary J. Rogers, Lindsay G. A. McKay, Laura E. Avena, Rebecca I. Johnson, Nadia Storm, Anthony Griffiths & Sidi A. Bencherif. (2021) Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID‐19 Vaccines. Advanced Science 8:18.
Crossref
Crossref
Kwinten Sliepen, Edith Schermer, Ilja Bontjer, Judith A. Burger, Réka Felfödiné Lévai, Philipp Mundsperger, Philip J. M. Brouwer, Monica Tolazzi, Attila Farsang, Dietmar Katinger, John P. Moore, Gabriella Scarlatti, Robin J. Shattock, Quentin J. Sattentau & Rogier W. Sanders. (2021) Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers. npj Vaccines 6:1.
Crossref
Crossref
Francesca Mancini, Francesca Micoli, Francesca Necchi, Mariagrazia Pizza, Francesco Berlanda Scorza & Omar Rossi. (2021) GMMA-Based Vaccines: The Known and The Unknown. Frontiers in Immunology 12.
Crossref
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Crossref
Zirong Dong, Wenjuan Liu, Kaiheng Liu, Yi Lu, Wei Wu, Jianping Qi & Zhongjian Chen. (2021) Effects on immunization of the physicochemical parameters of particles as vaccine carriers. Drug Discovery Today 26:7, pages 1712-1720.
Crossref
Crossref
Zhehui Peng, Jun Wu, Kangfeng Wang, Xin Li, Peng Sun, Lulu Zhang, Jing Huang, Yan Liu, Xiaoting Hua, Yunsong Yu, Chao Pan, Hengliang Wang & Li Zhu. (2021)
Production of a Promising Biosynthetic Self‐Assembled Nanoconjugate Vaccine against
Klebsiella Pneumoniae
Serotype O2 in a General
Escherichia Coli
Host
. Advanced Science 8:14.
Crossref
Crossref
Zhuxuan Jiang, Jican Liu, Juan Guan, Huan Wang, Tianhao Ding, Jun Qian & Changyou Zhan. (2021) Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines. Nano Letters 21:11, pages 4744-4752.
Crossref
Crossref
Zachary R. SiaXuedan HeAli ZhangJann C. AngShuai Shao, Amal SeffouhWei-Chiao HuangMichael R. D’AgostinoAmir Teimouri Dereshgi, Sambhara Suryaprakash, Joaquin OrtegaHanne Andersen, Matthew S. Miller, Bruce A. Davidson & Jonathan F. Lovell. (2021) A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge. Proceedings of the National Academy of Sciences 118:22.
Crossref
Crossref
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, Esmaeel Sharifi, Yapei Zhang, Piergiuseppe De Berardinis, Ali Zarrabi, Rajender S. Varma, Franklin R. Tay, Bryan Ronain Smith & Pooyan Makvandi. (2021) Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. Nano Today 38, pages 101119.
Crossref
Crossref
Giselle Rangel, Juan Bárcena, Noelia Moreno, Carlos P. Mata, José R. Castón, Alí Alejo & Esther Blanco. (2021) Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs. Vaccines 9:5, pages 470.
Crossref
Crossref
Mai N. Vu, Hannah G. Kelly, Hyon‐Xhi Tan, Jennifer A. Juno, Robyn Esterbauer, Thomas P. Davis, Nghia P. Truong, Adam K. Wheatley & Stephen J. Kent. (2021) Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Advanced Healthcare Materials 10:10.
Crossref
Crossref
Mojgan Allahyari, Samira amiri, Alireza Vatanara & Majid Golkar. (2021) Protection and Immune Responses Elicited by rSAG1-PLGA Nanoparticles in C57BL/6 Against Toxoplasma gondii. Journal of Medical Microbiology and Infectious Diseases 9:1, pages 38-45.
Crossref
Crossref
Brigette C. Duckworth & Joanna R. Groom. (2021) Conversations that count: Cellular interactions that drive T cell fate. Immunological Reviews 300:1, pages 203-219.
Crossref
Crossref
Philip J.M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Marloes Grobben, Mathieu Claireaux, Marlon de Gast, Romain Marlin, Virginie Chesnais, Ségolène Diry, Joel D. Allen, Yasunori Watanabe, Julia M. Giezen, Gius Kerster, Hannah L. Turner, Karlijn van der Straten, Cynthia A. van der Linden, Yoann Aldon, Thibaut Naninck, Ilja Bontjer, Judith A. Burger, Meliawati Poniman, Anna Z. Mykytyn, Nisreen M.A. Okba, Edith E. Schermer, Marielle J. van Breemen, Rashmi Ravichandran, Tom G. Caniels, Jelle van Schooten, Nidhal Kahlaoui, Vanessa Contreras, Julien Lemaître, Catherine Chapon, Raphaël Ho Tsong Fang, Julien Villaudy, Kwinten Sliepen, Yme U. van der Velden, Bart L. Haagmans, Godelieve J. de Bree, Eric Ginoux, Andrew B. Ward, Max Crispin, Neil P. King, Sylvie van der Werf, Marit J. van Gils, Roger Le Grand & Rogier W. Sanders. (2021) Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell 184:5, pages 1188-1200.e19.
Crossref
Crossref
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder & Kristy M. Ainslie. (2021) Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases. Advanced NanoBiomed Research 1:3.
Crossref
Crossref
Philip J. M. Brouwer, Aleksandar Antanasijevic, Marlon de Gast, Joel D. Allen, Tom P. L. Bijl, Anila Yasmeen, Rashmi Ravichandran, Judith A. Burger, Gabriel Ozorowski, Jonathan L. Torres, Celia LaBranche, David C. Montefiori, Rajesh P. Ringe, Marit J. van Gils, John P. Moore, Per Johan Klasse, Max Crispin, Neil P. King, Andrew B. Ward & Rogier W. Sanders. (2021) Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles. npj Vaccines 6:1.
Crossref
Crossref
Hui Xuan Lim, Jianhua Lim, Seyed Davoud Jazayeri, Sibrandes Poppema & Chit Laa Poh. (2021) Development of multi-epitope peptide-based vaccines against SARS-CoV-2. Biomedical Journal 44:1, pages 18-30.
Crossref
Crossref
Susan Krueger, Joseph E. Curtis, Daniel R. Scott, Alexander Grishaev, Greg Glenn, Gale Smith, Larry Ellingsworth, Oleg Borisov & Ernest L. Maynard. (2020) Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution. Molecular Pharmaceutics 18:1, pages 359-376.
Crossref
Crossref
Phornsiri PechsrichuangSupannika NamwongnaoAlain Jacquet. (2021) Bioengineering of Virus-like Particles for the Prevention or Treatment of Allergic Diseases. Allergy, Asthma & Immunology Research 13:1, pages 23.
Crossref
Crossref
David Wibowo, Sytze H.T. Jorritsma, Zennia Jean Gonzaga, Benjamin Evert, Shuxiong Chen & Bernd H.A. Rehm. (2021) Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials 268, pages 120597.
Crossref
Crossref
Maria Aurora Grimaudo. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy
303
315
.
K. Michael Pollard. (2020) Perspective: The Lung, Particles, Fibers, Nanomaterials, and Autoimmunity. Frontiers in Immunology 11.
Crossref
Crossref
Steven Rockman, Karen L. Laurie, Simone Parkes, Adam Wheatley & Ian G. Barr. (2020) New Technologies for Influenza Vaccines. Microorganisms 8:11, pages 1745.
Crossref
Crossref
Yaping Chen, Ji Wang, Xiangling Li, Ning Hu, Nicolas H. Voelcker, Xi Xie & Roey Elnathan. (2020) Emerging Roles of 1D Vertical Nanostructures in Orchestrating Immune Cell Functions. Advanced Materials 32:40.
Crossref
Crossref
Mingqiang HaoBeibei ChenXiaoyi ZhaoNana Zhao & Fu-Jian Xu. (2020) Organic/inorganic nanocomposites for cancer immunotherapy. Materials Chemistry Frontiers 4:9, pages 2571-2609.
Crossref
Crossref
María Q. Marín, Kwinten Sliepen, Juan García-Arriaza, Sylvie M. Koekkoek, Patricia Pérez, Carlos Óscar S. Sorzano, Carmen E. Gómez, Rogier W. Sanders & Mariano Esteban. (2020) Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV. Vaccines 8:3, pages 440.
Crossref
Crossref
Yanqi Chan, Seyed Davoud Jazayeri, Babu Ramanathan & Chit Laa Poh. (2020) Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles. Vaccines 8:3, pages 417.
Crossref
Crossref
Susan Thrane, Kara-Lee Aves, Ida E. M Uddbäck, Christoph M. Janitzek, Julianna Han, Yuhe R. Yang, Andrew B. Ward, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Allan R. Thomsen, Jan P. Christensen & Adam F. Sander. (2020) A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice. Vaccines 8:3, pages 389.
Crossref
Crossref
Hannah G. Kelly, Hyon-Xhi Tan, Jennifer A. Juno, Robyn Esterbauer, Yi Ju, Wenbo Jiang, Verena C. Wimmer, Brigette C. Duckworth, Joanna R. Groom, Frank Caruso, Masaru Kanekiyo, Stephen J. Kent & Adam K. Wheatley. (2020) Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight 5:10.
Crossref
Crossref
Darrell J. Irvine & Eric L. Dane. (2020) Enhancing cancer immunotherapy with nanomedicine. Nature Reviews Immunology 20:5, pages 321-334.
Crossref
Crossref
Lampouguin Yenkoidiok-Douti & Christopher M. Jewell. (2020) Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases. ACS Biomaterials Science & Engineering 6:2, pages 759-778.
Crossref
Crossref
Kara-Lee Aves, Louise Goksøyr & Adam F. Sander. (2020) Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines. Viruses 12:2, pages 185.
Crossref
Crossref
L. A. Dykman, O. A. Volokh, O. V. Gromova, O. S. Durakova, S. A. Vorobeva, M. N. Kireev, L. F. Livanova, A. K. Nikiforov, S. Y. Shchyogolev & V. V. Kutyrev. (2020) Obtaining and Characteristic of Antibodies to Vibrio cholerae Protective Antigens Conjugated with Gold Nanoparticles. Doklady Biochemistry and Biophysics 490:1, pages 19-21.
Crossref
Crossref
Marina A. Dobrovolskaia. (2019) Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies. Molecules 24:24, pages 4620.
Crossref
Crossref
Sanne Duinkerken, R. Eveline Li, Floortje J. van Haften, Tanja D. de Gruijl, Fabrizio Chiodo, Sjoerd T.T. Schetters & Yvette van Kooyk. (2019) Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells. Current Opinion in Chemical Biology 53, pages 167-172.
Crossref
Crossref
Yuhua Yang, Yibang Zhang, Aneesh Thakur, Ruyan Li, Han Xu, Zhixin Wang, Mahdi Ghavami, Zhigang Tu & Hanqing Liu. (2019) One-pot synthesis and characterization of ovalbumin-conjugated gold nanoparticles: A comparative study of adjuvanticity against the physical mixture of ovalbumin and gold nanoparticles. International Journal of Pharmaceutics 571, pages 118704.
Crossref
Crossref
Colin Havenar-Daughton, Diane G. Carnathan, Archana V. Boopathy, Amit A. Upadhyay, Ben Murrell, Samantha M. Reiss, Chiamaka A. Enemuo, Etse H. Gebru, Yury Choe, Pallavi Dhadvai, Federico Viviano, Kirti Kaushik, Jinal N. Bhiman, Bryan Briney, Dennis R. Burton, Steven E. Bosinger, William R. Schief, Darrell J. Irvine, Guido Silvestri & Shane Crotty. (2019) Rapid Germinal Center and Antibody Responses in Non-human Primates after a Single Nanoparticle Vaccine Immunization. Cell Reports 29:7, pages 1756-1766.e8.
Crossref
Crossref
Xiangru Feng, Weiguo Xu, Zhongmin Li, Wantong Song, Jianxun Ding & Xuesi Chen. (2019) Immunomodulatory Nanosystems. Advanced Science 6:17.
Crossref
Crossref
. (2019) The role of nanoparticles for biomedical application. Asian Biomedicine 13:4, pages 121-122.
Crossref
Crossref
Mitch Brinkkemper & Kwinten Sliepen. (2019) Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies. Vaccines 7:3, pages 76.
Crossref
Crossref
Stephen M Laidlaw & Lynn B Dustin. (2019) An HCV Vaccine on the Fly. The Journal of Infectious Diseases.
Crossref
Crossref